Form 8-K - Current report:
SEC Accession No. 0001564590-14-005468
Filing Date
2014-11-12
Accepted
2014-11-12 07:00:20
Documents
2
Period of Report
2014-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atra-8k_20141112.htm 8-K 26456
2 EX-99.1 atra-ex991_201411126.htm EX-99.1 234861
  Complete submission text file 0001564590-14-005468.txt   262437
Mailing Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005 415-287-2410
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36548 | Film No.: 141211009
SIC: 2836 Biological Products, (No Diagnostic Substances)